Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
NCT06925984
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
OligoProgressive Metastatic Disease
Interventions
RADIATION:
SBRT
Sponsor
Jules Bordet Institute